Physician profile
Jeffrey Holmes
NPI 1679912208
$508,732.16
in general payments reported to CMS, 2019-2025
34 companies · $79K in 2025
The $79K reported for 2025 was more than what 99% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $29K · 2020: $53K · 2021: $46K · 2022: $87K · 2023: $120K · 2024: $96K · 2025: $79K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $175K · Royalty Or License: $74K · Travel and Lodging: $28K · Food and Beverage: $12K · Honoraria: $6,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $174,609.44 |
| Royalty Or License | $74,068.19 |
| Travel and Lodging | $28,224.46 |
| Food and Beverage | $11,508.51 |
| Honoraria | $6,000.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trilliant Surgical LLC. | $178,174.45 | 2019-2025 | Arsenal Ankle 10 Hole 1/3 Tubular Plate, Arsenal Ankle, Arsenal Sinus Support Plate |
| Flower Orthopedics Coporation | $105,999.32 | 2019-2025 | Fibula Nail, 4.5mm X 130mm, Titanium, Flex-Thread, Fibula Nail, 3.5mm X 180mm, Titanium, Flex-Thread, Zero Profile Interlocking Cortex Screw, 2.7mm X 14mm, T8, Flex-Thread |
| Anika Therapeutics, INC. | $63,832.34 | 2020-2023 | Tactoset, Tactoset Foot & Ankle Place Holder, X-Twist |
| Medshape, INC. | $58,992.21 | 2021-2025 | Dynanail Helix, Washer, 15 Mm, Dynanail, Dynanail Mini |
| Parcus Medical, LLC | $25,981.48 | 2019-2020 | |
| Restor3d, INC. | $21,527.24 | 2022-2025 | |
| Trimed, INC. | $18,327.90 | 2021-2023 | |
| Ortho Solutions INC | $15,347.01 | 2022-2025 | |
| Stryker Corporation | $6,602.60 | 2019-2025 | Inbone, Prophecy, Invision |
| Wright Medical Technology, INC. | $4,869.58 | 2019-2020 | |
| Avitus Orthopaedics, INC. | $2,188.94 | 2019-2023 | |
| New Standard Device, LLC Dba Metalogix | $2,150.00 | 2022 | |
| Encore Medical, LP | $803.17 | 2021-2022 | |
| Arthrosurface Incorporated | $761.92 | 2019-2020 | |
| Treace Medical Concepts, INC. | $536.49 | 2024 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $534.72 | 2019-2020 | |
| Kuros Biosciences USA, INC | $377.52 | 2025 | Magnetos |
| Fusion Orthopedics USA, LLC | $230.13 | 2025 | |
| Nvision Biomedical Technologies, INC. | $175.23 | 2020 | |
| Linvatec Corporation | $171.64 | 2020-2025 | Biobrace 23mm |
| Smith+Nephew, INC. | $166.41 | 2020-2023 | Evos, Spatial Frame, Smart Tsf |
| Abbvie INC. | $148.86 | 2021-2022 | |
| Orthofix Medical, INC. | $145.89 | 2020-2023 | Physio-Stim |
| Goode Surgical INC | $120.75 | 2019 | |
| X-Spine Systems, INC. | $113.94 | 2019 | |
| Biogennix, LLC | $102.37 | 2022-2023 | Agilon |
| Mimedx Group, INC. | $82.63 | 2024 | |
| Sanara Medtech INC. | $77.36 | 2024 | Celleraterx |
| International Life Sciences | $62.50 | 2024 | Flexband |
| Avanos Medical | $48.03 | 2021 | |
| Medline Industries LP | $42.81 | 2019 | |
| Horizon Therapeutics Plc | $19.00 | 2020 | |
| Kci USA, INC. | $17.72 | 2023 | V.A.C. Dermatac, Promogran Prisma, Activ.A.C. |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$208.89 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Holmes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.